| Title： | Chinese expert consensus recommendations for management of thyroiditis and thyroid dysfunction in female patients with early breast cancer (2024 edition) |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinicians specializing in breast diseases in China |
| Evidence classification method： | The evidence grading system was developed by incorporating elements of the GRADE system along with insights gleaned from clinical studies conducted in China and expert clinical experience. |
| Development unit： | Breast Cancer Rehabilitation Committee of China Anti-Cancer Association, The Society of Clinical Cancer Research Administration of China Anti-Cancer Association, Breast surgery expert working group of Surgeons Branch of Chinese Medical Doctor Association, the Breast Cancer Expert Committee of the National Cancer Quality Control Center, Chongqing Federation of Clinical Medical Research, The Society of Thyroid Disease of Chongqing Association of the Integration of Traditional and Western Medicine, The Society of Onco-endocrinology of Chongqing Anti-Cancer Association |
| Registration time: | 2024-09-03 |
| Registration number： | PREPARE-2024CN390 |
| Purpose of the guideline: | The coexistence of thyroiditis and thyroid dysfunction in breast cancer patients is widely observed, impacting the treatment and prognosis of breast cancer patients. In long-term survival cases of breast cancer, there is a notable high incidence of accompanying thyroiditis and thyroid dysfunction, a trend that has gained increasing attention in recent years. Currently, there is a lack of consensus or guidelines regarding the diagnosis and treatment of thyroiditis and thyroid dysfunction in breast cancer patients. Based on the recent related documents, domestic and foreign guidelines and clinical experience of multiple clinical centers, The Society of Clinical Cancer Research Administration of China Anti-Cancer Association, in collaboration with The Society of Clinical Cancer Research Administration of China Anti-Cancer Association, The Society of Breast Cancer Integration and Rehabilitation of China Anti-Cancer Association, Chongqing Federation of Clinical Medical Research, The Society of Thyroid Disease of Chongqing Association of the Integration of Traditional and Western Medicine and The Society of Onco-endocrinology of Chongqing Anti-Cancer Association, has organized relevant experts to extensively discuss and formulate the " Chinese expert consensus recommendations for management of thyroiditis and thyroid dysfunction in female patients with breast cancer (2024 edition)", aiming to standardize the diagnosis and treatment of thyroiditis and thyroid function disorders in breast cancer patients, and improve the patients’ prognosis. |
Latest registration
